Sunday, December 17th | 29 Kislev 5778

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
January 6, 2016 1:50 pm

Tel Aviv Researchers Develop Innovative Therapy to Treat Incurable Blood Cancer

avatar by JNS.org

Email a copy of "Tel Aviv Researchers Develop Innovative Therapy to Treat Incurable Blood Cancer" to a friend
A micrograph of mantle cell lymphoma. Tel Aviv University (TAU) researchers have developed an innovative system that may treat the incurable blood cancer. Photo: Nephron via Wikimedia Commons.

A micrograph of mantle cell lymphoma. Tel Aviv University (TAU) researchers have developed an innovative system that may treat the incurable blood cancer. Photo: Nephron via Wikimedia Commons.

JNS.org – Tel Aviv University (TAU) researchers have developed an innovative system that may treat an incurable blood cancer.

A recently published study revealed that using RNA therapy can successfully stop the reproduction of cancer-related protein in white blood cells in both animals and samples from human mantle cell lymphoma (MCL) patients.

The research was led by Prof. Dan Peer of TAU’s Department of Cell Research and Immunology, and conducted by TAU Ph.D. students Shiri Weinstein and Itai Toker, in collaboration with Prof. Pia Raanani of Rabin Medical Center and Prof. Arnon Nagler of Sheba Medical Center.

MCL is known as the most aggressive blood cancer, and affects 3,000 Americans every year. The cancer has a survival rate of five to seven years after diagnosis, with limited systemic therapeutic drug therapies available.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner
  • clara wilkes

    Will this treatment work for Leukemia CLL?
    I would love to be free of this awful disease.

Algemeiner.com